Brief: Hemcheck Gets A First Evaluation Order From Deutsches Herzzentrum Berlin
June 2 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* SAID ON WEDNESDAY GETS A FIRST EVALUATION ORDER FROM
DEUTSCHES
HERZZENTRUM BERLIN
* ORDER IS OF MINOR FINANCIAL VALUE BUT THERE IS A
POSSIBILITY OF
MORE AND LARGER ORDERS IN THE FUTURE
* ORDER IS FOR HAEMOLYSIS DETECTION FOR DIAGNOSTIC USE
Source text for Eikon: urn:newsml:reuters.com:*:nWkr4bjHrf
Further company coverage: [ HEMC.ST ]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln